Diagnosis and management of hemangiomas and vascular malformations of the head and neck

Oral Diseases

Volumn 16, Issue 5, 2010, Pages 405-418

  Buckmiller, L M ^a   Richter, G T ^a   Suen, J Y ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Arteriovenous; Hemangiomas; Lymphatic; Malformations; Vascular anomalies; Venous

Indexed keywords

ETHYLENE VINYL ALCOHOL COPOLYMER; ONYX; PROPRANOLOL; UNCLASSIFIED DRUG;

ARTERIOVENOUS MALFORMATION; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONGENITAL BLOOD VESSEL MALFORMATION; HEAD AND NECK MALFORMATION; HEALTH CARE PERSONNEL; HEMANGIOMA; HUMAN; LOW LEVEL LASER THERAPY; LYMPH VESSEL; LYMPHATIC MALFORMATION; PATHOGENESIS; PERIPHERAL BLOOD VESSEL MALFORMATION; PHYSICIAN; PRIORITY JOURNAL; REFLUX; REVIEW; SOMNOLENCE; SUBGLOTTIC HEMANGIOMA; VEIN DISEASE; CLASSIFICATION; HEAD; HEAD AND NECK NEOPLASMS; LYMPHOID TISSUE; MULTIMODALITY CANCER THERAPY; NECK; VASCULAR MALFORMATIONS; VASCULARIZATION;

COMBINED MODALITY THERAPY; HEAD; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; LYMPHOID TISSUE; NECK; VASCULAR MALFORMATIONS;

EID: 77953211467     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01661.x     Document Type: Review

References (114)

1. Acevedo JL, Shah RK, Brietzke SE (2008). Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg 138 : 418-424.
2. Adams DM (2001). The nonsurgical management of vascular lesions. Facial Plast Surg Clin North Am 9 : 601-608.
3. Alomari AI, Karian VE et al (2006). Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol 17 : 1639-1648.
4. Arat A, Cil BE et al (2007). Embolization of high-flow craniofacial vascular malformations with onyx. AJNR Am J Neuroradiol 28 : 1409-1414.
5. Bai Y, Jia J et al (2009). Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg 67 : 251-256.
6. Barnes CM, Christison-Lagay EA et al (2007). The placenta theory and the origin of infantile hemangioma. Lymphat Res Biol 5 : 245-255.
7. Bauman NM, Burke DK et al (1997). Treatment of massive or life-threatening hemangiomas with recombinant alpha(2a)-interferon. Otolaryngol Head Neck Surg 117 : 99-110.
8. Bischoff J (2009). Progenitor cells in infantile hemangioma. J Craniofac Surg 20 (Suppl. 1) 695-697.
9. Bisdorff A, Mulliken JB et al (2007). Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations. AJNR Am J Neuroradiol 28 : 335-341.
10. Blei F (2008). Congenital lymphatic malformations. Ann N Y Acad Sci 1131 : 185-194.
11. Boon LM, Mulliken JB et al (1994). Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 3 : 1583-1587.
12. Boon LM, Mulliken JB et al (2004). Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol 140 : 971-976.
13. Bradley JP, Zide BM et al (1999). Large arteriovenous malformations of the face: aesthetic results with recurrence control. Plast Reconstr Surg 103 : 351-361.
14. Bruder E, Perez-Atayde AR et al (2009). Vascular lesions of bone in children, adolescents, and young adults. A clinicopathologic reappraisal and application of the ISSVA classification. Virchows Arch 454 : 161-179.
15. Buckmiller LM (2009). Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg 17 : 458-459.
16. Buckmiller LM, Francis CL et al (2008). Intralesional steroid injection for proliferative parotid hemangiomas. Int J Pediatr Otorhinolaryngol 72 : 81-87.
17. Buckmiller L, Dyamenahalli U et al (2009). Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope 119 : 2051-2054.
18. Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT (2010). Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center. Laryngoscope [Epub ahead of print].
19. Burrows PE, Mitri RK et al (2008). Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 6 : 209-216.
20. Chang J, Most D et al (1999). Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg 103 : 1-9 discussion 10.
21. Chang EI, Thangarajah H et al (2007). Hypoxia, hormones, and endothelial progenitor cells in hemangioma. Lymphat Res Biol 5 : 237-243.
22. Chang LC, Haggstrom AN et al (2008). Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 122 : 360-367.
23. Chen WL, Huang ZQ et al (2009). Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin. Head Neck [Epub ahead of print].
24. Chiller KG, Frieden IJ et al (2003). Molecular pathogenesis of vascular anomalies: classification into three categories based upon clinical and biochemical characteristics. Lymphat Res Biol 1 : 267-281.
25. Cohen JE, Gomori JM et al (2009). Complete and persistent occlusion of arteriovenous malformations of the mandible after endovascular embolization. Neurol Res 31 : 467-471.
26. Deboer MD, Boston BA (2008). Failure-to-thrive in an infant following injection of capillary hemangioma with triamcinolone acetonide. Clin Pediatr (Phila) 47 : 296-299.
27. Denoyelle F, Leboulanger N et al (2009). Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 73 : 1168-1172.
28. Drolet BA, Esterly NB et al (1999). Hemangiomas in children. N Engl J Med 341 : 173-181.
29. Drolet BA, Swanson EA et al (2008). Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 153 : 712-715.
30. Duyka LJ, Fan CY et al (2009). Progesterone receptors identified in vascular malformations of the head and neck. Otolaryngol Head Neck Surg 141 : 491-495.
31. Erdmann MW, Jackson JE et al (1995). Multidisciplinary approach to the management of head and neck arteriovenous malformations. Ann R Coll Surg Engl 77 : 53-59.
32. Fawcett SL, Grant I et al (2004). Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 57 : 168-171.
33. Fayad LM, Hazirolan T et al (2008). Venous malformations: MR imaging features that predict skin burns after percutaneous alcohol embolization procedures. Skeletal Radiol 37 : 895-901.
34. Fledelius HC, Illum N et al (2001). Interferon-alfa treatment of facial infantile haemangiomas: with emphasis on the sight-threatening varieties. A clinical series. Acta Ophthalmol Scand 79 : 370-373.
35. Frieden IJ, Drolet BA (2009). Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol 26 : 642-644.
36. Frischer JS, Huang J et al (2004). Biomolecular markers and involution of hemangiomas. J Pediatr Surg 39 : 400 404.
37. Garzon MC, Huang JT et al (2007). Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol 56 : 541-564.
38. Glade RS, Buckmiller LM (2009). CO(2) laser resurfacing of intraoral lymphatic malformations: a 10-year experience. Int J Pediatr Otorhinolaryngol [Epub ahead of print].
39. Glade RS, Richter GT et al (2009). Diagnosis and Management of Pediatric Cervicofacial Venous Malformations: retrospective Review from a Vascular Anomalies Center. Laryngoscope 120, 229-235.
40. Goyal R, Watts P et al (2004). Adrenal suppression and failure to thrive after steroid injections for periocular hemangioma. Ophthalmology 111 : 389-395.
41. Greene AK, Kim S et al (2008). Risk of vascular anomalies with Down syndrome. Pediatrics 121 : e135-e140.
42. Haggstrom AN, Drolet BA et al (2006). Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 118 : 882-887.
43. Haggstrom AN, Drolet BA et al (2007). Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 150 : 291-294.
44. Itakura E, Yamamoto H et al (2009). VEGF-C and VEGFR-3 in a series of lymphangiomas: is superficial lymphangioma a true lymphangioma? Virchows Arch 454 : 317-325.
45. Jackson IT, Keskin M et al (2005). Compartmentalization of massive vascular malformations. Plast Reconstr Surg 115 : 10-21.
46. Jacobs AH (1957). Strawberry hemangiomas; the natural history of the untreated lesion. Calif Med 86 : 8-10.
47. Jahan R, Murayama Y et al (2001). Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 48 : 984-995 discussion 995-997.
48. Jalil S, Akhtar J et al (2006). Corticosteroids therapy in the management of infantile cutaneous hemangiomas. J Coll Physicians Surg Pak 16 : 662-665.
49. Jeffree RL, Stoodley MA (2009). Postnatal development of arteriovenous malformations. Pediatr Neurosurg 45 : 296-304.
50. Jeong HS, Baek CH et al (2006). Treatment for extracranial arteriovenous malformations of the head and neck. Acta Otolaryngol 126 : 295-300.
51. Kane WJ, Morris S et al (1995). Significant hemangiomas and vascular malformations of the head and neck: clinical management and treatment outcomes. Ann Plast Surg 35 : 133-143.
52. Khan ZA, Boscolo E et al (2008). Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 118 : 2592-2599.
53. Kim JY, Kim DI et al (2006). Surgical treatment for congenital arteriovenous malformation: 10 years? experience. Eur J Vasc Endovasc Surg 32 : 101-106.
54. Kim AH, Ko HK et al (2009). Percutaneous radiofrequency ablation: a novel treatment of facial venous malformation. J Vasc Surg 50 : 424-427.
55. Kishimoto Y, Hirano S et al (2008). Endoscopic KTP laser photocoagulation therapy for pharyngolaryngeal venous malformations in adults. Ann Otol Rhinol Laryngol 117 : 881-885.
56. Kleinman ME, Blei F et al (2005). Circulating endothelial progenitor cells and vascular anomalies. Lymphat Res Biol 3 : 234-239.
57. Kleinman ME, Greives MR et al (2007). Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol 27 : 2664-2670.
58. Kohout MP, Hansen M et al (1998). Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg 102 : 643-654.
59. Leaute-Labreze C, Dumas de la Roque E et al (2008). Propranolol for severe hemangiomas of infancy. N Engl J Med 358 : 2649-2651.
60. Lee BB, Do YS et al (2004). Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 39 : 590-600.
61. Lee KB, Kim DI et al (2008). Incidence of soft tissue injury and neuropathy after embolo/sclerotherapy for congenital vascular malformation. J Vasc Surg 48 : 1286-1291.
62. Lee IH, Kim KH et al (2009a). Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results. Korean J Radiol 10 : 269-276.
63. Lee SJ, Shin DJ et al (2009b). A fraction of deep vascular birthmarks are true deep hemangiomas of infancy. Int J Dermatol 48 : 817-821.
64. Lei ZM, Huang XX et al (2007). Surgery of lymphatic malformations in oral and cervicofacial regions in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 : 338-344.
65. Leon-Villapalos J, Wolfe K et al (2005). GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 58 : 348-352.
66. Limaye N, Wouters V et al (2009). Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet 41 : 118-124.
67. MacFie CC, Jeffery SL (2008). Diagnosis of vascular skin lesions in children: an audit and review. Pediatr Dermatol 25 : 7-12.
68. Mavrikakis I, Heran MK et al (2009). The role of thrombosis as a mechanism of exacerbation in venous and combined venous lymphatic vascular malformations of the orbit. Ophthalmology 116 : 1216-1224.
69. Meijer-Jorna LB, Breugem CC et al (2009). Presence of a distinct neural component in congenital vascular malformations relates to the histological type and location of the lesion. Hum Pathol 40 : 1467-1473.
70. Metry D, Heyer G et al (2009). Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 124 : 1447-1456.
71. Mimura H, Fujiwara H et al (2009). Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief. Eur Radiol 19 : 2474-2480.
72. Mounayer C, Hammami N et al (2007). Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 28 : 518-523.
73. Mulliken JB, Glowacki J (1982). Classification of pediatric vascular lesions. Plast Reconstr Surg 70 : 120-121.
74. Mulliken JB, Zetter BR et al (1982). In vitro characteristics of endothelium from hemangiomas and vascular malformations. Surgery 92 : 348-353.
75. Nehra D, Jacobson L et al (2008). Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg 43 : 451-460.
76. North PE, Waner M et al (2001). Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol 137 : 1607-1620.
77. North PE, Waner M et al (2002). Are infantile hemangiomas of placental origin? Ophthalmology 109 : 633-634. (Pubitemid 34270116)
78. O TM, Alexander RE et al (2009). Segmental hemangiomas of the upper airway. Laryngoscope 119 : 2242-2247.
79. Orlow SJ, Isakoff MS et al (1997). Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution. J Pediatr 131 : 643-646.
80. Panagiotopoulos V, Gizewski E et al (2009). Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 30 : 99-106.
81. Pavlov KA, Dubova EA et al (2009). Expression of growth factors in endotheliocytes in vascular malformations. Bull Exp Biol Med 147 : 366-370.
82. Perez J, Pardo J et al (2002). Vincristine - an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol 41 : 197-199.
83. Perkins JA, Tempero RM et al (2007). Clinical outcomes in lymphocytopenic lymphatic malformation patients. Lymphat Res Biol 5 : 169-174.
84. Perkins JA, Maniglia C et al (2008). Clinical and radiographic findings in children with spontaneous lymphatic malformation regression. Otolaryngol Head Neck Surg 138 : 772-777.
85. Perkins JA, Chen EY et al (2009). Proposal for staging airway hemangiomas. Otolaryngol Head Neck Surg 141 : 516-521.
86. Poldervaart MT, Breugem CC et al (2009). Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature. J Craniofac Surg 20 : 1159-1162.
87. Pope E, Krafchik BR et al (2007). Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 119 : e1239-e1247.
88. Pransky SM, Canto C (2004). Management of subglottic hemangioma. Curr Opin Otolaryngol Head Neck Surg 12 : 509-512.
89. Ravindranathan H, Gillis J et al (2008). Intensive care experience with sclerotherapy for cervicofacial lymphatic malformations. Pediatr Crit Care Med 9 : 304-309.
90. Richter GT, Suen J et al (2007). Arteriovenous malformations of the tongue: a spectrum of disease. Laryngoscope 117 : 328-335.
91. Ronchese F (1953). The spontaneous involution of cutaneous vascular tumors. Am J Surg 86 : 376-386.
92. Sans V, Dumas de la Roque E et al (2009). Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics [Epub ahead of print].
93. Schumacher M, Ernemann U et al (2008). Treatment of venous malformations - comparison to lymphatic malformations. Lymphology 41 : 139-146.
94. Seccia A, Salgarello M et al (1999). Combined radiological and surgical treatment of arteriovenous malformations of the head and neck. Ann Plast Surg 43 : 359-366.
95. Shiels WE 2nd., Kang DR et al (2009). Percutaneous treatment of lymphatic malformations. Otolaryngol Head Neck Surg 141 : 219-224.
96. Siegfried EC, Keenan WJ et al (2008). More on propranolol for hemangiomas of infancy. N Engl J Med 359 : 2846 author reply 2846-2847.
97. Simic R, Vlahovic A et al (2009). Treatment of nasal hemangiomas. Int J Pediatr Otorhinolaryngol [Epub ahead of print].
98. Smith MC, Zimmerman MB et al (2009). Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 119 : 107-115.
99. Smoller BR, Rosen S (1986). Port-wine stains. A disease of altered neural modulation of blood vessels? Arch Dermatol 122 : 177-179.
100. Sun ZJ, Zhao YF et al (2007). Mast cells in hemangioma: a double-edged sword. Med Hypotheses 68 : 805-807.
101. Sun ZY, Yang L et al (2008). Possibilities and potential roles of estrogen in the pathogenesis of proliferation hemangiomas formation. Med Hypotheses 71 : 286-292.
102. Taki W, Yonekawa Y et al (1990). A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol 11 : 163 168.
103. Torer B, Gulcan H et al (2007). PHACES syndrome with small, late-onset hemangiomas. Eur J Pediatr 166 : 1293-1295.
104. Uehara S, Osuga K et al (2009). Intralesional sclerotherapy for subcutaneous venous malformations in children. Pediatr Surg Int 25 : 709-713.
105. Vikkula M, Boon LM et al (2001). Molecular genetics of vascular malformations. Matrix Biol 20 : 327-335.
106. Wang Y, Qi F et al (2009). Endothelial cell culture of intramuscular venous malformation and its invasive behavior related to matrix metalloproteinase-9. Plast Reconstr Surg 123 : 1419-1430.
107. Wiatrak BJ, Reilly JS et al (1996). Open surgical excision of subglottic hemangioma in children. Int J Pediatr Otorhinolaryngol 34 : 191-206.
108. Wiegand S, Eivazi B et al (2008). Pathogenesis of lymphangiomas. Virchows Arch 453 : 1-8.
109. Wu IC, Orbach DB (2009). Neurointerventional management of high-flow vascular malformations of the head and neck. Neuroimaging Clin N Am 19 : 219-240.
110. Wu JK, Bisdorff A et al (2005). Auricular arteriovenous malformation: evaluation, management, and outcome. Plast Reconstr Surg 115 : 985-995.
111. Yu Y, Flint AF et al (2004). Endothelial progenitor cells in infantile hemangioma. Blood 103 : 1373-1375.
112. Zeng RS, Liu XQ et al (2008). Sequential treatment of giant lymphatic malformation of the tongue combined with severe oral and maxillofacial deformities. J Oral Maxillofac Surg 66 : 2364-2371.
113. Zheng JW, Yang XJ et al (2009). Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients. Oral Oncol 45 : 872-876.
114. Ziyeh S, Strecker R et al (2005). Dynamic 3D MR angiography of intra- and extracranial vascular malformations at 3T: a technical note. AJNR Am J Neuroradiol 26 : 630-634.